Marketplace

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Zika infection

image_1.jpeg

Newswise — WASHINGTON (August 29, 2016) — As Zika continues to dominate news headlines and political discussions, the O’Neill Institute for National and Global Health Law Colloquium hosts “Zika Virus: Our Common Future,” a panel discussion led by Anthony Fauci, MD,

Medicine

Channels:

Fertility, Infertility, IVF, Pregnancy

Greenwich Fertility Center Offers the Newest Treatment Options: January 20 Event Explains Advanced Reproductive Technologies

Chances of becoming parents are constantly increasing with options that now include improved embryology laboratory techniques including day-5 blastocyst transfers, single embryo transfers, egg freezing, preimplantation genetic testing (PGD), and egg and sperm donation, all of which will be discussed Jan. 20 at Greenwich Hospital.

Medicine

Channels:

Nurses' Long Work Hours, Scheduling Can Increase Patient Mortality

trinkoff.jpg

Patient deaths from pneumonia and acute myocardial infarction increased significanly in hospitals where nurses reported long hours and less down time.

Medicine

Channels:

Electronic Medical Records, American Recovery And Reinvestment Act, Arra

UT Southwestern to Accelerate Its Early Leadership in Using Electronic Health Records to Improve Patient Care

As the first major medical center in North Texas to implement electronic medical records in all its clinical practice groups, UT Southwestern Medical Center today applauded the government’s initiative to get hospitals and health care providers across the nation to embrace new health care technology.

Medicine

Channels:

Clinical Trial, Cancer Clinical Trials, Melanoma, hydroxychloroquine, Autophagy, New Jersey

Clinical Trial Studies Safety of Malaria Drug for Melanoma Use

Building upon recent laboratory discoveries on resistance by cancer cells to therapies that attempt to starve cancer, scientists at New Jersey’s only NCI Comprehensive Cancer Center are conducting a clinical trial that further explores how to prevent that action. The goal is to discover if an anti-malaria drug is able to block a cellular process that acts as a survival method for malignant cells in human melanoma.

Medicine

Channels:

Bipolar CHOICE , Case Western Reserve University School Of Medicine, University Hospitals Case Medical Center, psychiatry clinical trial

Case Western Reserve/UH Launch Bipolar Trial Site

The Mood Disorders Program at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, along with the Bipolar Trials Network, is launching Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness).

Medicine

Channels:

National Children's Study, Case Western Reserve University School Of Medicine, Pregnant Women

Case Western Reserve Launches the National Children’s Study

Residents of Cuyahoga County, and later Lorain County, will soon have the opportunity to contribute to the establishment of a national resource for childhood growth and development. The National Children’s Study is the largest, long-term study of children’s health ever conducted in the U.S.

Medicine

Channels:

Drug Testing, Drug Abuse, Alcohol And Drug Abuse, Alcohol Abuse

Nail and Hair Samples Show Alcohol Consumption Over Last 90 Days

USDTLimageforstory.jpg

United States Drug Testing Laboratories (USDTL) launched two new tests for monitoring long-term alcohol exposure on Friday. Using fingernail and hair specimens, the new assay is the first and only test to report a donor’s alcohol exposure for the past 90 days reliably.

Medicine

Channels:

Clinical Trial Data, pharmaceutical companites, Generic Medications, Drug Development, Licensing

How Do Data Exclusivity Periods Affect Pharmaceutical Innovation?

A new study is the first to calculate the financial and social costs of limiting access to trial data — and finds that extending the term of exclusive access will lead to higher drug costs in the short term but also to more than 200 extra drug approvals and to greater life expectancy in the next several decades.

Medicine

Mayo Clinic First in U.S. to Use Newly-Approved FDA Technology to Treat Atrial Fibrillation

Mayo Clinic is the first in the U.S. to use the first minimally invasive freezing balloon technology for the treatment of atrial fibrillation (AF) approved in December by the U.S. Food and Drug Administration. The first patient received the treatment Tuesday, Jan. 4.







Chat now!